We are pleased to announce the opening of our BASE shop, making it easier for customers to purchase 5-ALA supplements. This shop has been created for those who are interested in 5-ALA, as well as for those who wish to support the diabetes research and social implementation initiatives being advanced by Biozipcode Inc. Our goal ...

GDT Community is pleased to share an important update in the progress of the diabetes cure project. The research program that has been built through years of work at Shiga University of Medical Science has now moved its academic base to the Department of Biocommunication Development, Kyoto University Graduate School of Medicine and Faculty of ...

We are excited to announce the official launch of the Global Development Token (GDT) website. Here, you can explore our mission to complete a cure for diabetes, learn about the innovative Biozipcode™ technology, and stay updated on our latest news and project milestones. Visit regularly to discover new insights, upcoming events, and opportunities to join ...

May 22, 2025 — Research originating from Shiga University of Medical Science and its spin-off Biozipcode, Inc. has been highlighted in major Japanese media, including Yahoo! News Japan and ASCII.jp. The coverage focused on a promising new therapeutic approach to diabetes that aims not only to manage blood sugar but to fundamentally repair the abnormal ...

This week in Dubai marked an important step toward advancing our mission to achieve a complete cure for diabetes. We had the privilege of welcoming H.E. Peter Adelbai, Ambassador of the Republic of Palau to Japan, and Professor Hideto Kojima of Shiga University of Medical Science. The gathering, held together with Mr. James Park, Managing ...

We would like to provide the latest update regarding the issuance and distribution structure of PWDT and GDT, as well as the future operational framework of the related projects. At present, the regulatory framework for Virtual Asset Service Providers (VASPs) in the Republic of Palau remains under review pending formal approval by the Financial Intelligence ...

Our team recently visited the Republic of Palau with a clear mission: to establish the nation as a model country for achieving a complete cure for diabetes. The delegation included members from Shiga University of Medical Science, former Minister for IT Policy and former Member of the House of Representatives Mr. Naokazu Takemoto, and Mr. ...

Silicon Valley, USA — We were honored to present at the Japan Innovation Campus, an initiative hosted by the Ministry of Economy, Trade and Industry (METI), operated by Mori Building Co., Ltd. and Mori Building Palo Alto, Inc., and partnered with JETRO. The event serves as a bridge between Japan’s most promising ventures and leading ...

July 29, 2024 — Professor Hideto Kojima of Shiga University of Medical Science delivered a featured presentation on Biozipcode™ technology at an international conference focused on gene therapy. The session, organized by SLDDDRS and AnGes, gathered more than 20 representatives from key Japanese and U.S. research agencies, including JST, AMED, JSPS, JETRO, NEDO, NICT, NIH, ...

June 2024 — At ENDO 2024, the annual meeting of the Endocrine Society and one of the world’s leading gatherings of endocrinology experts, our research team presented a scientific poster entitled “Diabetes Stem Cells: A Common Target for Abnormal Insulin Secretion and Insulin Resistance.” This year’s meeting attracted thousands of scientists, clinicians, and industry leaders ...